- Report
- August 2025
- 198 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP
- Report
- August 2025
- 181 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP
- Report
- August 2025
- 195 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP
- Report
- August 2025
- 182 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP
- Report
- April 2026
- 181 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 365 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 378 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 267 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 180 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 282 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 182 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 377 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 288 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 383 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 377 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 466 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 287 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 419 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 483 Pages
Global
From €5171EUR$5,850USD£4,480GBP
- Report
- April 2026
- 279 Pages
Global
From €5171EUR$5,850USD£4,480GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more